BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 10491544)

  • 1. Late complications of therapy in 213 children with localized, nonorbital soft-tissue sarcoma of the head and neck: A descriptive report from the Intergroup Rhabdomyosarcoma Studies (IRS)-II and - III. IRS Group of the Children's Cancer Group and the Pediatric Oncology Group.
    Raney RB; Asmar L; Vassilopoulou-Sellin R; Klein MJ; Donaldson SS; Green J; Heyn R; Wharam M; Glicksman AS; Gehan EA; Anderson J; Maurer HM
    Med Pediatr Oncol; 1999 Oct; 33(4):362-71. PubMed ID: 10491544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term effects in children treated with radiotherapy for head and neck rhabdomyosarcoma.
    Paulino AC; Simon JH; Zhen W; Wen BC
    Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1489-95. PubMed ID: 11121653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ascending myelitis after intensive chemotherapy and radiation therapy in children with cranial parameningeal sarcoma.
    Raney B; Tefft M; Heyn R; Newton W; Jones PM; Haeberlen V; Maurer H
    Cancer; 1992 Mar; 69(6):1498-506. PubMed ID: 1540886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of localized nonorbital, nonparameningeal head and neck rhabdomyosarcoma: lessons learned from intergroup rhabdomyosarcoma studies III and IV.
    Pappo AS; Meza JL; Donaldson SS; Wharam MD; Wiener ES; Qualman SJ; Maurer HM; Crist WM
    J Clin Oncol; 2003 Feb; 21(4):638-45. PubMed ID: 12586800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved prognosis with intensive treatment of children with cranial soft tissue sarcomas arising in nonorbital parameningeal sites. A report from the Intergroup Rhabdomyosarcoma Study.
    Raney RB; Tefft M; Newton WA; Ragab AH; Lawrence W; Gehan EA; Maurer HM
    Cancer; 1987 Jan; 59(1):147-55. PubMed ID: 3791141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of children and adolescents with localized parameningeal sarcoma: experience of the Intergroup Rhabdomyosarcoma Study Group protocols IRS-II through -IV, 1978-1997.
    Raney RB; Meza J; Anderson JR; Fryer CJ; Donaldson SS; Breneman JC; Fitzgerald TJ; Gehan EA; Michalski JM; Ortega JA; Qualman SJ; Sandler E; Wharam MD; Wiener ES; Maurer HM; Crist WM
    Med Pediatr Oncol; 2002 Jan; 38(1):22-32. PubMed ID: 11835233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperfractionated radiation in children with rhabdomyosarcoma--results of an Intergroup Rhabdomyosarcoma Pilot Study.
    Donaldson SS; Asmar L; Breneman J; Fryer C; Glicksman AS; Laurie F; Wharam M; Gehan EA
    Int J Radiat Oncol Biol Phys; 1995 Jul; 32(4):903-11. PubMed ID: 7607964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of radiation therapy parameters on outcome in children treated with radiation therapy for localized parameningeal rhabdomyosarcoma in Intergroup Rhabdomyosarcoma Study Group trials II through IV.
    Michalski JM; Meza J; Breneman JC; Wolden SL; Laurie F; Jodoin M; Raney B; Wharam MD; Donaldson SS
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1027-38. PubMed ID: 15234036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late effects of therapy in 94 patients with localized rhabdomyosarcoma of the orbit: Report from the Intergroup Rhabdomyosarcoma Study (IRS)-III, 1984-1991.
    Raney RB; Anderson JR; Kollath J; Vassilopoulou-Sellin R; Klein MJ; Heyn R; Glicksman AS; Wharam M; Crist WM; Maurer HM
    Med Pediatr Oncol; 2000 Jun; 34(6):413-20. PubMed ID: 10842248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late effects after treatment of twenty children with soft tissue sarcomas of the head and neck. Experience at a single institution with a review of the literature.
    Fromm M; Littman P; Raney RB; Nelson L; Handler S; Diamond G; Stanley C
    Cancer; 1986 May; 57(10):2070-6. PubMed ID: 3955515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soft tissue sarcoma of the head and neck in childhood: nonorbital and nonparameningeal sites. A report of the Intergroup Rhabdomyosarcoma Study (IRS)-I.
    Wharam MD; Foulkes MA; Lawrence W; Lindberg RD; Maurer HM; Newton WA; Ragab AH; Raney RB; Tefft M
    Cancer; 1984 Feb; 53(4):1016-9. PubMed ID: 6692285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soft-tissue sarcomas of the head and neck in children.
    Littman P; Raney B; Zimmerman R; Handler S; Nelson L; Diamond G; Bilaniuk L
    Int J Radiat Oncol Biol Phys; 1983 Sep; 9(9):1367-71. PubMed ID: 6309711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Intergroup Rhabdomyosarcoma Study-II.
    Maurer HM; Gehan EA; Beltangady M; Crist W; Dickman PS; Donaldson SS; Fryer C; Hammond D; Hays DM; Herrmann J
    Cancer; 1993 Mar; 71(5):1904-22. PubMed ID: 8448756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary chemotherapy with or without radiation therapy and/or surgery for children with localized sarcoma of the bladder, prostate, vagina, uterus, and cervix. A comparison of the results in Intergroup Rhabdomyosarcoma Studies I and II.
    Raney RB; Gehan EA; Hays DM; Tefft M; Newton WA; Haeberlen V; Maurer HM
    Cancer; 1990 Nov; 66(10):2072-81. PubMed ID: 2224761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Which patients with microscopic disease and rhabdomyosarcoma experience relapse after therapy? A report from the soft tissue sarcoma committee of the children's oncology group.
    Smith LM; Anderson JR; Qualman SJ; Crist WM; Paidas CN; Teot LA; Pappo AS; Link MP; Grier HE; Wiener ES; Breneman JC; Raney RB; Maurer HM; Donaldson SS
    J Clin Oncol; 2001 Oct; 19(20):4058-64. PubMed ID: 11600608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rhabdomyosarcoma and undifferentiated sarcoma in the first two decades of life: a selective review of intergroup rhabdomyosarcoma study group experience and rationale for Intergroup Rhabdomyosarcoma Study V.
    Raney RB; Anderson JR; Barr FG; Donaldson SS; Pappo AS; Qualman SJ; Wiener ES; Maurer HM; Crist WM
    J Pediatr Hematol Oncol; 2001 May; 23(4):215-20. PubMed ID: 11846299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of cyclophosphamide dose for patients with subset 2 low-risk rhabdomyosarcoma is associated with an increased risk of recurrence: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
    Walterhouse DO; Pappo AS; Meza JL; Breneman JC; Hayes-Jordan A; Parham DM; Cripe TP; Anderson JR; Meyer WH; Hawkins DS
    Cancer; 2017 Jun; 123(12):2368-2375. PubMed ID: 28211936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local tumor control in rhabdomyosarcoma following low-dose irradiation: comparison of group II and select group III patients.
    Regine WF; Fontanesi J; Kumar P; Ayers D; Bowman LC; Pappo AS; Coffey DH; Avery L; Rao BN; Kun LE
    Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):485-91. PubMed ID: 7852110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results from the IRS-IV randomized trial of hyperfractionated radiotherapy in children with rhabdomyosarcoma--a report from the IRSG.
    Donaldson SS; Meza J; Breneman JC; Crist WM; Laurie F; Qualman SJ; Wharam M;
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):718-28. PubMed ID: 11597814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ewing's sarcoma of soft tissues in childhood: a report from the Intergroup Rhabdomyosarcoma Study, 1972 to 1991.
    Raney RB; Asmar L; Newton WA; Bagwell C; Breneman JC; Crist W; Gehan EA; Webber B; Wharam M; Wiener ES; Anderson JR; Maurer HM
    J Clin Oncol; 1997 Feb; 15(2):574-82. PubMed ID: 9053479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.